Practice Areas
Theresa Kavanaugh is a senior partner in the firm’s nationally recognized Life Sciences group, and the co-founder of Goodwin’s Late Stage Drug Development practice. She represents both early stage and mature life science companies worldwide on development and implementation of complex patent and market exclusivity strategies. She has substantial experience and a deep understanding of preparing for and positioning patent and regulatory strategy for M&A, company partnering, and financing events including public offerings; her strategic patent counseling has helped her clients achieve significant acquisition valuation and early stage funding.
Theresa has led patent portfolio strategy for many therapeutics that have gained FDA and worldwide regulatory approval.
Personal
JD, 2005
Northeastern University School of Law
Doctor of Philosophy, Chemistry, 1992
Massachusetts Institute of Technology
MS, Chemistry, 1987
The University of Texas at Austin
BS, Chemistry, 1986
University of California